drugset / Trial / NCT00053482
Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The objective of this study is to determine the minimum dose of ACAM2000 needed to produce a cutaneous reaction in at least 90% of a population of healthy adults at least 28 years of age and previously vaccinated against smallpox.
Timeline
- Start
- 2003-01
- Primary completion
- 2003-04
- Completion
- 2003-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ACAM2000 | Vaccine | 1e-08 unknown | — |
| Subject | ACAM2000 | Vaccine | 1e-07 unknown | — |
| Subject | ACAM2000 | Vaccine | 2e-07 unknown | — |
| Subject | ACAM2000 | Vaccine | 5e-06 unknown | — |
| Comparator | Vaccinia virus (calf lymph) smallpox vaccine | Vaccine | 1e-08 unknown | — |